SARS-CoV-2 survival on skin and its transfer from contaminated surfaces
PLOS One · 20.06.2025 · 20 (6) · e0325235
DOI: 10.1371/journal.pone.0325235 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 20.06.2025. Verfasst von Ana K Pitol und 5 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool School of Tropical Medicine, Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Diseases, Liverpool,…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Skin, Fomites. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LSTM Director’s Catalyst Fund, The National Institute for Health & Social Care Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections, The Pandemic Institute.
Abstract (Originalsprache)
Understanding the transmission dynamics of SARS-CoV-2, particularly its transfer from contaminated surfaces (fomites) to human skin, is crucial for mitigating the spread of COVID-19. While extensive research has examined the persistence of SARS-CoV-2 on various surfaces, there is limited understanding of how efficiently it transfers to human skin, and how long it survives on the skin. This study investigates two key aspects of SARS-CoV-2 transmission: (1) the transfer efficiency of SARS-CoV-2 from non-porous (plastic and metal) and porous (cardboard) surfaces to a 3D human skin model (LabSkin), and (2) the survival of SARS-CoV-2 on the skin under different temperature conditions. First, we validated LabSkin as a suitable surrogate for human skin by comparing the transfer efficiency of the bacteriophage Phi 6 from surfaces to LabSkin and to human volunteers’ fingers. No significant differences were observed, confirming LabSkin’s suitability for these studies. Subsequently, the transfer of SARS-CoV-2 from surfaces to LabSkin was assessed, showing that plastic and metal surfaces had similar transfer efficiencies (~13%), while no transfer occurred from cardboard once the inoculum had dried on the surface. Finally, the survival of SARS-CoV-2 on skin was assessed, showing a rapid decay at higher temperatures, with a half-life ranging from 2.8 to 17.8 hours depending on the temperature. These findings enhance our understanding of viral transmission via fomites and inform public health strategies to reduce the risk of SARS-CoV-2 transmission through surface contact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Liverpool School of Tropical Medicine, Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Diseases, Liverpool, United Kingdom.
- Unilever Research and Development, Port Sunlight, United Kingdom.
ORCID-Profile: Ana K Pitol, Michael Hoptroff, Grant L Hughes
Förderung
- LSTM Director’s Catalyst Fund
- The National Institute for Health & Social Care Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections
- The Pandemic Institute
- UK Research and Innovation
- Biotechnology and Biological Sciences Research Council
- Engineering and Physical Sciences Research Council
- Royal Society Wolfson Fellowship
- The National Institute for Health & Social Care Research
Zitieren
APA
Pitol, A. K., Venkatesan, S., Richards, S., Hoptroff, M., Majumdar, A., & Hughes, G. L. (2025). SARS-CoV-2 survival on skin and its transfer from contaminated surfaces. PLOS One, 20(6), e0325235. https://doi.org/10.1371/journal.pone.0325235
Vancouver
Pitol AK, Venkatesan S, Richards S, Hoptroff M, Majumdar A, Hughes GL. SARS-CoV-2 survival on skin and its transfer from contaminated surfaces. PLOS One. 2025;20(6):e0325235. doi:10.1371/journal.pone.0325235
BibTeX
@article{Pitol2025,
author = {Pitol, Ana K and Venkatesan, Samiksha and Richards, Siobhan and Hoptroff, Michael and Majumdar, Amitabha and Hughes, Grant L},
title = {SARS-CoV-2 survival on skin and its transfer from contaminated surfaces},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {6},
pages = {e0325235},
doi = {10.1371/journal.pone.0325235}
}
EUVIMED